Jürgen Horst

Title: Jürgen Horst: Innovator in Genetic Research

Introduction

Jürgen Horst is a notable inventor based in Münster, Germany, recognized for his contributions to genetic research. With a focus on the annexin A5 gene, he holds two patents that delve into the complexities of genetic variations and their implications for diagnostics. His work is pivotal in advancing our understanding of genetic regulation and its potential applications in healthcare.

Latest Patents

Horst's latest patents revolve around a genetic variant of the annexin A5 (ANXA5) gene, specifically concerning a nucleic acid molecule comprising a regulatory element with key point mutations at specific nucleotide positions. These mutations include G to A at nucleotide 186, A to C at nucleotide 203, T to C at nucleotide 229, and G to A at nucleotide 276 of SEQ ID NO: 2. The patents also outline a method for haplotyping the ANXA5 gene regulation element in individuals, providing valuable insights for diagnostics and personalized medicine.

Career Highlights

Throughout his career, Jürgen Horst has worked in esteemed institutions such as the Universitätsklinikum Münster, where he has been instrumental in conducting cutting-edge research. His expertise in genetic regulation has positioned him as a prominent figure in the field, and his patents reflect a commitment to improving diagnostic techniques through genetic analysis.

Collaborations

Horst has collaborated with notable professionals in the field, including Nadja Bogdanova and Volker Gerke. Their collective expertise and research initiatives have contributed significantly to advancing knowledge in genetic regulation and its potential medical applications.

Conclusion

In summary, Jürgen Horst's innovations in genetic research underscore the importance of understanding genetic variants and their diagnostic uses. His contributions, reflected in his patents, serve as a foundation for future advancements in personalized medicine and genetic diagnostics.